Vascular endothelial growth factor (VEGF)
G_VEGFWhat does this word mean?
The pro-angiogenic factor whose expression is upregulated by PDRN, forming the basis of therapeutic angiogenesis.
Expanded note
The angiogenesis evidence is strongest in ischemic wound settings such as diabetic foot ulcers and peripheral artery occlusive disease, where human controlled studies exist. Extrapolating this to say that topical PDRN promotes hair growth or new blood vessels in healthy skin has no supporting evidence.
Not a generic example.
The title of PMID 19860658 is itself a study of PDRN inducing therapeutic angiogenesis.
Related terms
Where this term appears
Educational reference only. This site does not provide medical advice, treatment courses, injection counts, clinic recommendations or price recommendations.
PDRN is not approved by the FDA for injection or any therapeutic use. Topical and injectable PDRN are parallel facts under different regulatory pathways and must not be directly equated.
PN is not PDRN. Evidence grades are labelled on every factual element; in vitro and animal research is never described as clinical efficacy.